In this episode, host Jae Encarnacion speaks with Javier Tordable, CEO of Pauling AI, a company revolutionizing drug discovery using artificial intelligence. Javier shares his motivation for founding Pauling AI: addressing the slow, costly, and low-success process of traditional drug development. He explains that Pauling AI helps scientists go from an idea to a testable molecule faster and more affordably, often reducing timelines from years to weeks.